Acupuncture and Pain Counseling in Reducing Pain and Symptom Distress in Hospitalized Cancer Patients
- Patients admitted to University of California San Francisco (UCSF) Mission Bay Hospital or Zuckerberg San Francisco General (ZSFG) with a malignant solid tumor (e.g., breast, gastrointestinal, genito-urologic, gynecologic, head and neck, lung cancers, or lymphoma)
- Speak Cantonese, English, or Spanish
- Have an anticipated stay of >= 48 hours
- Have pain intensity of >= 4 out of 10 for worst pain in the prior 24 hours when enrolled
- Acupuncture contraindication (e.g., sepsis)
- Unstable medical condition (e.g., severe pulmonary disease, myocardial infarction)
- Admission to the psychiatric ward (e.g., for severe depression)
- Inability to consent (e.g., cognitive impairment)
- Prior involvement with the study (e.g., readmissions)
- Platelets < 50,000 uL
- Absolute neutrophil count < 500 uL
- Clostridium (C.) difficile infection
I. Determine the effectiveness of adjunctive acupuncture and of pain counseling for improving pain management.
I. Determine the extent that adjunctive acupuncture and pain counseling reduce use of opioid analgesics and side effects.
I. Examine stakeholder perspectives on non-pharmacologic approaches to pain management.
OUTLINE: Patients are randomized to 1 of 4 arms.
ARM I: Along with standard of care pain medication, patients undergo acupuncture over 30-60 minutes on days 1-4.
ARM II: Along with standard of care pain medication, patients undergo pain counselling over 30-60 minutes on days 1-4.
ARM III: Along with standard of care pain medication, patients undergo acupuncture and pain counseling over 30-60 minutes on days 1-4.
ARM IV: Patients receive standard of care pain medication.
After patients are discharged from the hospital, they will be followed up within 3 days and at 1 and 3 months.
Trial Phase Phase NA
Trial Type Supportive care
UCSF Medical Center-Mount Zion
- Primary ID 18801
- Secondary IDs NCI-2018-02204, 17-23446
- Clinicaltrials.gov ID NCT03905720